GO:0006790 | sulfur compound metabolic process | 5.88% (6/102) | 4.08 | 2e-06 | 0.001089 |
GO:1901566 | organonitrogen compound biosynthetic process | 8.82% (9/102) | 2.83 | 6e-06 | 0.001173 |
GO:0044237 | cellular metabolic process | 28.43% (29/102) | 1.28 | 4e-06 | 0.001237 |
GO:0051536 | iron-sulfur cluster binding | 3.92% (4/102) | 4.88 | 1.2e-05 | 0.0015 |
GO:0051540 | metal cluster binding | 3.92% (4/102) | 4.88 | 1.2e-05 | 0.0015 |
GO:0009532 | plastid stroma | 3.92% (4/102) | 4.39 | 4.5e-05 | 0.003076 |
GO:0009570 | chloroplast stroma | 3.92% (4/102) | 4.39 | 4.5e-05 | 0.003076 |
GO:1990904 | ribonucleoprotein complex | 6.86% (7/102) | 3.0 | 3.1e-05 | 0.003214 |
GO:0009987 | cellular process | 35.29% (36/102) | 0.94 | 4.1e-05 | 0.003593 |
GO:0044249 | cellular biosynthetic process | 11.76% (12/102) | 1.97 | 6.1e-05 | 0.003768 |
GO:0044391 | ribosomal subunit | 3.92% (4/102) | 4.16 | 8.2e-05 | 0.004219 |
GO:0034641 | cellular nitrogen compound metabolic process | 15.69% (16/102) | 1.55 | 0.000103 | 0.004268 |
GO:0008152 | metabolic process | 31.37% (32/102) | 0.97 | 9e-05 | 0.00429 |
GO:0009067 | aspartate family amino acid biosynthetic process | 2.94% (3/102) | 5.23 | 7.7e-05 | 0.004336 |
GO:0005575 | cellular_component | 36.27% (37/102) | 0.86 | 9.9e-05 | 0.004383 |
GO:1901576 | organic substance biosynthetic process | 11.76% (12/102) | 1.84 | 0.000134 | 0.005171 |
GO:0044281 | small molecule metabolic process | 9.8% (10/102) | 2.04 | 0.000167 | 0.005427 |
GO:0009066 | aspartate family amino acid metabolic process | 2.94% (3/102) | 4.88 | 0.000159 | 0.005459 |
GO:0006807 | nitrogen compound metabolic process | 25.49% (26/102) | 1.08 | 0.000152 | 0.005552 |
GO:0071704 | organic substance metabolic process | 29.41% (30/102) | 0.94 | 0.00022 | 0.006473 |
GO:0009058 | biosynthetic process | 11.76% (12/102) | 1.77 | 0.000215 | 0.006659 |
GO:0009117 | nucleotide metabolic process | 4.9% (5/102) | 3.07 | 0.000351 | 0.009885 |
GO:0006753 | nucleoside phosphate metabolic process | 4.9% (5/102) | 3.06 | 0.000368 | 0.009903 |
GO:0110165 | cellular anatomical entity | 31.37% (32/102) | 0.83 | 0.000547 | 0.010587 |
GO:0005488 | binding | 37.25% (38/102) | 0.72 | 0.000567 | 0.010628 |
GO:0006553 | lysine metabolic process | 1.96% (2/102) | 5.91 | 0.000534 | 0.010654 |
GO:0009085 | lysine biosynthetic process | 1.96% (2/102) | 5.91 | 0.000534 | 0.010654 |
GO:0051588 | regulation of neurotransmitter transport | 0.98% (1/102) | 10.94 | 0.000509 | 0.010867 |
GO:2000300 | regulation of synaptic vesicle exocytosis | 0.98% (1/102) | 10.94 | 0.000509 | 0.010867 |
GO:0046928 | regulation of neurotransmitter secretion | 0.98% (1/102) | 10.94 | 0.000509 | 0.010867 |
GO:0080171 | lytic vacuole organization | 0.98% (1/102) | 10.94 | 0.000509 | 0.010867 |
GO:0007040 | lysosome organization | 0.98% (1/102) | 10.94 | 0.000509 | 0.010867 |
GO:0046483 | heterocycle metabolic process | 13.73% (14/102) | 1.45 | 0.000606 | 0.011031 |
GO:0003674 | molecular_function | 51.96% (53/102) | 0.56 | 0.000433 | 0.011168 |
GO:0018105 | peptidyl-serine phosphorylation | 2.94% (3/102) | 4.17 | 0.000664 | 0.011418 |
GO:0018209 | peptidyl-serine modification | 2.94% (3/102) | 4.17 | 0.000664 | 0.011418 |
GO:0055086 | nucleobase-containing small molecule metabolic process | 4.9% (5/102) | 2.84 | 0.000712 | 0.011907 |
GO:0006725 | cellular aromatic compound metabolic process | 13.73% (14/102) | 1.41 | 0.000758 | 0.012341 |
GO:1903305 | regulation of regulated secretory pathway | 0.98% (1/102) | 10.2 | 0.000848 | 0.012809 |
GO:0050804 | modulation of chemical synaptic transmission | 0.98% (1/102) | 10.2 | 0.000848 | 0.012809 |
GO:0099177 | regulation of trans-synaptic signaling | 0.98% (1/102) | 10.2 | 0.000848 | 0.012809 |
GO:0044283 | small molecule biosynthetic process | 4.9% (5/102) | 2.67 | 0.0012 | 0.013262 |
GO:0099643 | signal release from synapse | 0.98% (1/102) | 9.52 | 0.001357 | 0.013334 |
GO:0099003 | vesicle-mediated transport in synapse | 0.98% (1/102) | 9.52 | 0.001357 | 0.013334 |
GO:0023061 | signal release | 0.98% (1/102) | 9.52 | 0.001357 | 0.013334 |
GO:0016079 | synaptic vesicle exocytosis | 0.98% (1/102) | 9.72 | 0.001188 | 0.013365 |
GO:1990849 | vacuolar localization | 0.98% (1/102) | 9.72 | 0.001188 | 0.013365 |
GO:0099078 | BORC complex | 0.98% (1/102) | 9.72 | 0.001188 | 0.013365 |
GO:0031082 | BLOC complex | 0.98% (1/102) | 9.72 | 0.001188 | 0.013365 |
GO:0031083 | BLOC-1 complex | 0.98% (1/102) | 9.72 | 0.001188 | 0.013365 |
GO:0032418 | lysosome localization | 0.98% (1/102) | 9.72 | 0.001188 | 0.013365 |
GO:0045055 | regulated exocytosis | 0.98% (1/102) | 9.72 | 0.001188 | 0.013365 |
GO:0016226 | iron-sulfur cluster assembly | 1.96% (2/102) | 5.28 | 0.001262 | 0.013473 |
GO:0031163 | metallo-sulfur cluster assembly | 1.96% (2/102) | 5.28 | 0.001262 | 0.013473 |
GO:0008150 | biological_process | 42.16% (43/102) | 0.6 | 0.001295 | 0.013587 |
GO:0000377 | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile | 2.94% (3/102) | 3.82 | 0.001328 | 0.013705 |
GO:0071011 | precatalytic spliceosome | 1.96% (2/102) | 5.5 | 0.000941 | 0.013862 |
GO:0000469 | obsolete cleavage involved in rRNA processing | 0.98% (1/102) | 9.94 | 0.001018 | 0.014003 |
GO:0008021 | synaptic vesicle | 0.98% (1/102) | 9.94 | 0.001018 | 0.014003 |
GO:0006396 | RNA processing | 5.88% (6/102) | 2.29 | 0.001533 | 0.014162 |
GO:0034513 | box H/ACA snoRNA binding | 0.98% (1/102) | 9.35 | 0.001527 | 0.014318 |
GO:0070382 | exocytic vesicle | 0.98% (1/102) | 9.35 | 0.001527 | 0.014318 |
GO:0030133 | transport vesicle | 0.98% (1/102) | 9.35 | 0.001527 | 0.014318 |
GO:1901360 | organic cyclic compound metabolic process | 13.73% (14/102) | 1.37 | 0.001 | 0.0144 |
GO:0051213 | dioxygenase activity | 2.94% (3/102) | 3.92 | 0.00109 | 0.014662 |
GO:0019637 | organophosphate metabolic process | 5.88% (6/102) | 2.37 | 0.001144 | 0.014758 |
GO:1902373 | negative regulation of mRNA catabolic process | 0.98% (1/102) | 9.2 | 0.001696 | 0.014787 |
GO:0048255 | mRNA stabilization | 0.98% (1/102) | 9.2 | 0.001696 | 0.014787 |
GO:0005737 | cytoplasm | 9.8% (10/102) | 1.61 | 0.001727 | 0.014846 |
GO:1901564 | organonitrogen compound metabolic process | 17.65% (18/102) | 1.09 | 0.001762 | 0.014944 |
GO:0000398 | mRNA splicing, via spliceosome | 2.94% (3/102) | 3.9 | 0.001138 | 0.014991 |
GO:0006163 | purine nucleotide metabolic process | 3.92% (4/102) | 3.0 | 0.001675 | 0.015025 |
GO:0000375 | RNA splicing, via transesterification reactions | 2.94% (3/102) | 3.71 | 0.001663 | 0.01514 |
GO:1901135 | carbohydrate derivative metabolic process | 4.9% (5/102) | 2.48 | 0.00212 | 0.017046 |
GO:0072521 | purine-containing compound metabolic process | 3.92% (4/102) | 2.91 | 0.002096 | 0.017073 |
GO:0046394 | carboxylic acid biosynthetic process | 3.92% (4/102) | 2.91 | 0.002091 | 0.017261 |
GO:0016053 | organic acid biosynthetic process | 3.92% (4/102) | 2.91 | 0.002091 | 0.017261 |
GO:0005681 | spliceosomal complex | 2.94% (3/102) | 3.55 | 0.002242 | 0.017569 |
GO:0044238 | primary metabolic process | 25.49% (26/102) | 0.82 | 0.002228 | 0.017678 |
GO:0035556 | intracellular signal transduction | 3.92% (4/102) | 2.87 | 0.002336 | 0.018075 |
GO:0072380 | TRC complex | 0.98% (1/102) | 8.72 | 0.002374 | 0.01814 |
GO:1901607 | alpha-amino acid biosynthetic process | 2.94% (3/102) | 3.52 | 0.002405 | 0.018156 |
GO:0030515 | snoRNA binding | 1.96% (2/102) | 4.77 | 0.002521 | 0.018577 |
GO:0000154 | rRNA modification | 1.96% (2/102) | 4.78 | 0.002498 | 0.018631 |
GO:0016628 | oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor | 1.96% (2/102) | 4.76 | 0.002578 | 0.018777 |
GO:0008380 | RNA splicing | 2.94% (3/102) | 3.47 | 0.002612 | 0.018801 |
GO:0010857 | calcium-dependent protein kinase activity | 1.96% (2/102) | 4.72 | 0.002707 | 0.019042 |
GO:0009931 | calcium-dependent protein serine/threonine kinase activity | 1.96% (2/102) | 4.72 | 0.002707 | 0.019042 |
GO:0004683 | calmodulin-dependent protein kinase activity | 1.96% (2/102) | 4.71 | 0.002755 | 0.019158 |
GO:0008652 | amino acid biosynthetic process | 2.94% (3/102) | 3.4 | 0.002992 | 0.020581 |
GO:0006139 | nucleobase-containing compound metabolic process | 11.76% (12/102) | 1.32 | 0.003063 | 0.020609 |
GO:0004853 | uroporphyrinogen decarboxylase activity | 0.98% (1/102) | 8.35 | 0.003051 | 0.020753 |
GO:0048205 | COPI coating of Golgi vesicle | 0.98% (1/102) | 8.2 | 0.003389 | 0.020772 |
GO:0031120 | snRNA pseudouridine synthesis | 0.98% (1/102) | 8.2 | 0.003389 | 0.020772 |
GO:0048200 | Golgi transport vesicle coating | 0.98% (1/102) | 8.2 | 0.003389 | 0.020772 |
GO:0019877 | diaminopimelate biosynthetic process | 0.98% (1/102) | 8.2 | 0.003389 | 0.020772 |
GO:0034719 | SMN-Sm protein complex | 0.98% (1/102) | 8.28 | 0.00322 | 0.020982 |
GO:0004801 | transaldolase activity | 0.98% (1/102) | 8.28 | 0.00322 | 0.020982 |
GO:0004496 | mevalonate kinase activity | 0.98% (1/102) | 8.28 | 0.00322 | 0.020982 |
GO:0005684 | U2-type spliceosomal complex | 1.96% (2/102) | 4.56 | 0.003381 | 0.021578 |
GO:0043186 | P granule | 0.98% (1/102) | 8.13 | 0.003558 | 0.021595 |
GO:0003735 | structural constituent of ribosome | 2.94% (3/102) | 3.34 | 0.003378 | 0.02178 |
GO:0016765 | transferase activity, transferring alkyl or aryl (other than methyl) groups | 2.94% (3/102) | 3.29 | 0.003706 | 0.021848 |
GO:0090407 | organophosphate biosynthetic process | 3.92% (4/102) | 2.69 | 0.00364 | 0.021877 |
GO:0015935 | small ribosomal subunit | 1.96% (2/102) | 4.49 | 0.00369 | 0.021962 |
GO:0003962 | cystathionine gamma-synthase activity | 0.98% (1/102) | 8.0 | 0.003897 | 0.022334 |
GO:0072588 | box H/ACA RNP complex | 0.98% (1/102) | 8.0 | 0.003897 | 0.022334 |
GO:0031429 | box H/ACA snoRNP complex | 0.98% (1/102) | 8.0 | 0.003897 | 0.022334 |
GO:0016702 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen | 1.96% (2/102) | 4.42 | 0.004082 | 0.023184 |
GO:1903312 | negative regulation of mRNA metabolic process | 0.98% (1/102) | 7.77 | 0.004573 | 0.025733 |
GO:0044271 | cellular nitrogen compound biosynthetic process | 5.88% (6/102) | 1.95 | 0.004806 | 0.0268 |
GO:0008897 | holo-[acyl-carrier-protein] synthase activity | 0.98% (1/102) | 7.62 | 0.00508 | 0.028074 |
GO:0042350 | GDP-L-fucose biosynthetic process | 0.98% (1/102) | 7.44 | 0.005755 | 0.028729 |
GO:0046368 | GDP-L-fucose metabolic process | 0.98% (1/102) | 7.44 | 0.005755 | 0.028729 |
GO:0050201 | fucokinase activity | 0.98% (1/102) | 7.44 | 0.005755 | 0.028729 |
GO:0042352 | GDP-L-fucose salvage | 0.98% (1/102) | 7.44 | 0.005755 | 0.028729 |
GO:0016631 | enoyl-[acyl-carrier-protein] reductase activity | 0.98% (1/102) | 7.44 | 0.005755 | 0.028729 |
GO:0007266 | Rho protein signal transduction | 0.98% (1/102) | 7.44 | 0.005755 | 0.028729 |
GO:0004318 | enoyl-[acyl-carrier-protein] reductase (NADH) activity | 0.98% (1/102) | 7.44 | 0.005755 | 0.028729 |
GO:0046777 | protein autophosphorylation | 1.96% (2/102) | 4.22 | 0.005322 | 0.029154 |
GO:0006397 | mRNA processing | 2.94% (3/102) | 3.05 | 0.005897 | 0.029204 |
GO:0008839 | 4-hydroxy-tetrahydrodipicolinate reductase | 0.98% (1/102) | 7.48 | 0.005586 | 0.029555 |
GO:0005094 | Rho GDP-dissociation inhibitor activity | 0.98% (1/102) | 7.48 | 0.005586 | 0.029555 |
GO:0022625 | cytosolic large ribosomal subunit | 1.96% (2/102) | 4.18 | 0.005585 | 0.030061 |
GO:0016701 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen | 1.96% (2/102) | 4.19 | 0.005552 | 0.030145 |
GO:0009150 | purine ribonucleotide metabolic process | 2.94% (3/102) | 2.96 | 0.006992 | 0.033551 |
GO:0003824 | catalytic activity | 28.43% (29/102) | 0.65 | 0.006952 | 0.03362 |
GO:0019287 | isopentenyl diphosphate biosynthetic process, mevalonate pathway | 0.98% (1/102) | 7.17 | 0.006936 | 0.033806 |
GO:0019346 | transsulfuration | 0.98% (1/102) | 7.17 | 0.006936 | 0.033806 |
GO:0050667 | homocysteine metabolic process | 0.98% (1/102) | 7.13 | 0.007104 | 0.033828 |
GO:0043489 | RNA stabilization | 0.98% (1/102) | 7.1 | 0.007273 | 0.034366 |
GO:0033875 | ribonucleoside bisphosphate metabolic process | 1.96% (2/102) | 3.93 | 0.007779 | 0.035147 |
GO:0033865 | nucleoside bisphosphate metabolic process | 1.96% (2/102) | 3.93 | 0.007779 | 0.035147 |
GO:0034032 | purine nucleoside bisphosphate metabolic process | 1.96% (2/102) | 3.93 | 0.007779 | 0.035147 |
GO:0003723 | RNA binding | 6.86% (7/102) | 1.64 | 0.007541 | 0.035362 |
GO:0032991 | protein-containing complex | 10.78% (11/102) | 1.22 | 0.007713 | 0.035628 |
GO:0006364 | rRNA processing | 2.94% (3/102) | 2.91 | 0.007674 | 0.035718 |
GO:0015934 | large ribosomal subunit | 1.96% (2/102) | 3.9 | 0.00817 | 0.036383 |
GO:0040031 | snRNA modification | 0.98% (1/102) | 6.94 | 0.008115 | 0.036401 |
GO:0004103 | choline kinase activity | 0.98% (1/102) | 6.91 | 0.008284 | 0.036625 |
GO:1901605 | alpha-amino acid metabolic process | 2.94% (3/102) | 2.84 | 0.008726 | 0.038309 |
GO:0019878 | lysine biosynthetic process via aminoadipic acid | 0.98% (1/102) | 6.82 | 0.008789 | 0.038311 |
GO:0047627 | adenylylsulfatase activity | 0.98% (1/102) | 6.8 | 0.008957 | 0.038502 |
GO:0016819 | hydrolase activity, acting on acid anhydrides, in sulfonyl-containing anhydrides | 0.98% (1/102) | 6.8 | 0.008957 | 0.038502 |
GO:0016627 | oxidoreductase activity, acting on the CH-CH group of donors | 1.96% (2/102) | 3.81 | 0.009165 | 0.039124 |
GO:0016072 | rRNA metabolic process | 2.94% (3/102) | 2.8 | 0.009492 | 0.040245 |
GO:0017005 | 3'-tyrosyl-DNA phosphodiesterase activity | 0.98% (1/102) | 6.69 | 0.00963 | 0.040549 |
GO:0005516 | calmodulin binding | 1.96% (2/102) | 3.76 | 0.009799 | 0.040984 |
GO:0060090 | molecular adaptor activity | 1.96% (2/102) | 3.75 | 0.009972 | 0.041149 |
GO:0044255 | cellular lipid metabolic process | 4.9% (5/102) | 1.95 | 0.009917 | 0.0412 |
GO:0072379 | ER membrane insertion complex | 0.98% (1/102) | 6.62 | 0.010134 | 0.041542 |
GO:0009259 | ribonucleotide metabolic process | 2.94% (3/102) | 2.76 | 0.010233 | 0.041674 |
GO:0015976 | carbon utilization | 0.98% (1/102) | 6.59 | 0.010302 | 0.041679 |
GO:0034457 | Mpp10 complex | 0.98% (1/102) | 6.52 | 0.010806 | 0.043434 |
GO:0007265 | Ras protein signal transduction | 0.98% (1/102) | 6.48 | 0.011142 | 0.044495 |
GO:0004594 | pantothenate kinase activity | 0.98% (1/102) | 6.44 | 0.011477 | 0.044682 |
GO:0005687 | U4 snRNP | 0.98% (1/102) | 6.44 | 0.011477 | 0.044682 |
GO:0004305 | ethanolamine kinase activity | 0.98% (1/102) | 6.46 | 0.01131 | 0.044875 |
GO:0019693 | ribose phosphate metabolic process | 2.94% (3/102) | 2.7 | 0.011417 | 0.045015 |
GO:0008333 | endosome to lysosome transport | 0.98% (1/102) | 6.37 | 0.011981 | 0.045778 |
GO:0015743 | malate transport | 0.98% (1/102) | 6.37 | 0.011981 | 0.045778 |
GO:0006901 | vesicle coating | 0.98% (1/102) | 6.37 | 0.011981 | 0.045778 |
GO:0016740 | transferase activity | 14.71% (15/102) | 0.92 | 0.012067 | 0.045824 |
GO:0015740 | C4-dicarboxylate transport | 0.98% (1/102) | 6.35 | 0.012148 | 0.045853 |
GO:0044272 | sulfur compound biosynthetic process | 1.96% (2/102) | 3.58 | 0.012477 | 0.046807 |
GO:0031118 | rRNA pseudouridine synthesis | 0.98% (1/102) | 6.3 | 0.012651 | 0.047176 |
GO:0070259 | tyrosyl-DNA phosphodiesterase activity | 0.98% (1/102) | 6.28 | 0.012819 | 0.047515 |
GO:0006656 | phosphatidylcholine biosynthetic process | 0.98% (1/102) | 6.26 | 0.012987 | 0.047566 |
GO:0070402 | NADPH binding | 0.98% (1/102) | 6.22 | 0.013322 | 0.047665 |
GO:0009228 | thiamine biosynthetic process | 0.98% (1/102) | 6.22 | 0.013322 | 0.047665 |
GO:0034309 | primary alcohol biosynthetic process | 0.98% (1/102) | 6.22 | 0.013322 | 0.047665 |
GO:0018193 | peptidyl-amino acid modification | 2.94% (3/102) | 2.63 | 0.012977 | 0.047814 |
GO:0005198 | structural molecule activity | 2.94% (3/102) | 2.62 | 0.013159 | 0.047913 |
GO:0006620 | post-translational protein targeting to endoplasmic reticulum membrane | 0.98% (1/102) | 6.18 | 0.013657 | 0.048583 |
GO:1902369 | negative regulation of RNA catabolic process | 0.98% (1/102) | 6.17 | 0.013824 | 0.048898 |
GO:0099503 | secretory vesicle | 0.98% (1/102) | 6.15 | 0.013992 | 0.049209 |